Evidence map›Paper›PMID 24893777›Full record

ArticleMalaria journal2014

Using infective mosquitoes to challenge monkeys with Plasmodium knowlesi in malaria vaccine studies.

Jittawadee R Murphy, Walter R Weiss, David Fryauff, Megan Dowler, Tatyana Savransky, Cristina Stoyanov, Olga Muratova, Lynn Lambert, Sachy Orr-Gonzalez, Katie Lynn Zeleski and 9 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Plasmodium knowlesi as a Threat to Global Public Health.The Korean journal of parasitology · 2015
    Review
  7. Article
  8. Tropical parasitology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Jittawadee R Murphy
Walter R WeissNaval Medical Research Center, Silver Spring, MD, USA. walter.weiss@verizon.net.
David Fryauff
Megan Dowler
Tatyana Savransky
Cristina Stoyanov
Olga Muratova
Lynn Lambert
Sachy Orr-Gonzalez
Katie Lynn Zeleski
Jessica Hinderer
Michael P Fay
Gyan Joshi
Robert W Gwadz
Thomas L Richie
Eileen Franke Villasante
Jason H Richardson
Patrick E Duffy
Jingyang Chen
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USNaval Medical Research Command · USWalter Reed Army Institute of Research · USFrederick National Laboratory for Cancer Research · USVector Oncology (United States) · US

Funding

Comparative Medicine Infectious Diseases- BethesdaZIGAI001047 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ELKINS, WILLIAM · 2009 to 2025
$535.6M
Pre-erythrocytic malaria vaccines: Discovery and Clinical DevelopmentZIAAI001135 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2010 to 2025
$6.4M
Studies on Arthropod Vectors of DiseaseZIAAI000629 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GWADZ, ROBERT · 2009 to 2014
$5.7M
Malaria Vaccine Based on Self-Assembling Polypeptide Nanoparticles (SAPN)R01AI068761 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI BURKHARD, PETER, LANAR, DAVID ERVIN · 2009 to 2012
$2.1M
Intramural NIH HHSNIAID NIH HHS 1R01AI068761-01A2PHS HHS HHSN272201000027C
6 · The paper itself

Abstract

backgroundWhen rhesus monkeys (Macaca mulatta) are used to test malaria vaccines, animals are often challenged by the intravenous injection of sporozoites. However, natural exposure to malaria comes via mosquito bite, and antibodies can neutralize sporozoites as they traverse the skin. Thus, intravenous injection may not fairly assess humoral immunity from anti-sporozoite malaria vaccines. To better assess malaria vaccines in rhesus, a method to challenge large numbers of monkeys by mosquito bite was developed.

methodsSeveral species and strains of mosquitoes were tested for their ability to produce Plasmodium knowlesi sporozoites. Donor monkey parasitaemia effects on oocyst and sporozoite numbers and mosquito mortality were documented. Methylparaben added to mosquito feed was tested to improve mosquito survival. To determine the number of bites needed to infect a monkey, animals were exposed to various numbers of P. knowlesi-infected mosquitoes. Finally, P. knowlesi-infected mosquitoes were used to challenge 17 monkeys in a malaria vaccine trial, and the effect of number of infectious bites on monkey parasitaemia was documented.

resultsAnopheles dirus, Anopheles crascens, and Anopheles dirus X (a cross between the two species) produced large numbers of P. knowlesi sporozoites. Mosquito survival to day 14, when sporozoites fill the salivary glands, averaged only 32% when donor monkeys had a parasitaemia above 2%. However, when donor monkey parasitaemia was below 2%, mosquitoes survived twice as well and contained ample sporozoites in their salivary glands. Adding methylparaben to sugar solutions did not improve survival of infected mosquitoes. Plasmodium knowlesi was very infectious, with all monkeys developing blood stage infections if one or more infected mosquitoes successfully fed. There was also a dose-response, with monkeys that received higher numbers of infected mosquito bites developing malaria sooner.

conclusionsAnopheles dirus, An. crascens and a cross between these two species all were excellent vectors for P. knowlesi. High donor monkey parasitaemia was associated with poor mosquito survival. A single infected mosquito bite is likely sufficient to infect a monkey with P. knowlesi. It is possible to efficiently challenge large groups of monkeys by mosquito bite, which will be useful for P. knowlesi vaccine studies.

Indexed as

AnimalsAnophelesFemaleMacaca mulattaMalariaMalaria VaccinesMalePlasmodium knowlesiSurvival AnalysisMalaria Vaccines

Identifiers

PMID24893777
PMCPMC4070636
OpenAlexW2166345652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.